Table 4.
Use and handling of non-invasive fetal test systems
| Characteristics | N (%) |
|---|---|
| Offer of first-trimester screening parallel to non-invasive prenatal test | |
| Yes | 27 (71.05) |
| No | 0 (0) |
| Optional | 11 (28.95) |
| Offer of non-invasive prenatal testing in a two-stage procedure before first trimester screening | |
| Yes | 6 (15.79) |
| Offer of non-invasive prenatal testing from a certain threshold after completion of the first trimester screening | |
| > 1:1000 | 10 (26.32) |
| > 1:500 | 11(28.95) |
| > 1:100 | 11(28.95) |
| No | 6 (15.79) |
| Offer of non-invasive prenatal testing after informed consent without performing first-trimester screening | |
| Yes | 15 (39.47) |
| The following question pertains to the provision of a non-invasive prenatal test | |
| Trisomy 21, 13 and 18 | 8 (21.1) |
| Trisomy 21, 13 and 18, monosomy and fetal sex | 24 (63.16) |
| Other diseases such as Di-George syndrome | 6 (15.79) |